Searchable abstracts of presentations at key conferences in endocrinology

ea0038p239 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Hypothalamic glucocorticoid levels increase in an in vivo model of glucocorticoid-induced obesity and hyperinsulinaemia

Sefton Charlotte , Harno Erika , Davies Alison , Small Helen , Allen Tiffany-Jayne , Wray Jonathan , Ramamoorthy Thanuja Gali , Coll Anthony P , White Anne

Glucocorticoid (Gc) excess, either endogenously produced (Cushing’s syndrome) or as a result of exogenous steroid treatment, can cause metabolic disorders such as obesity and hyperglycaemia. The contribution of centrally acting corticosterone in the development of these metabolic disorders is unknown. Gcs regulate the anorexigenic and orexigenic neuropeptides (POMC and AgRP) within the arcuate nucleus of the hypothalamus to modulate energy balance. This study investigated...